Perspective: Ivermectin for COVID-19 — Breakthrough Treatment or Hydroxychloroquine Redux?
Ivermectin for COVID-19 — Breakthrough Treatment or Hydroxychloroquine Redux? – HIV and ID Observations Related video: Ivermectin For COVID-19 | A Doctor Explains – ZDoggMD
The post Perspective: Ivermectin for COVID-19 — Breakthrough Treatment or Hydroxychloroquine Redux? appeared first on Links Medicus.
NIH Guideline Statement: “there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19”
The COVID-19 Treatment Guidelines Panel’s Statement on the Use of Ivermectin for the Treatment of COVID-19 – National Institutes of Health
The post NIH Guideline Statement: “there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19” appeared first on Links Medicus.
Opinion: RCTs don’t justify using convalescent plasma or antibody cocktails
RCTs don’t justify using convalescent plasma or antibody cocktails – PulmCrit
The post Opinion: RCTs don’t justify using convalescent plasma or antibody cocktails appeared first on Links Medicus.
Observational study: Among patients hospitalized with Covid-19 not receiving mechanical ventilation, transfusion of plasma with higher anti–SARS-CoV-2 IgG antibody levels is linked to lower risk of death than transfusion of plasma with lower antibody leve
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 – New England Journal of Medicine Editorial: (A Little) Clarity on Convalescent Plasma for Covid-19 – New England Journal of Medicine Commentaries: Expert reaction to study looking at convalescent plasma antibody levels and risk of death from COVID-19 – Science Media Centre AND Antibody-rich […]
The post Observational study: Among patients hospitalized with Covid-19 not receiving mechanical ventilation, transfusion of plasma with higher anti–SARS-CoV-2 IgG antibody levels is linked to lower risk of death than transfusion of plasma with lower antibody levels appeared first on Links Medicus.
[Preprint] Past COVID-19 infection provides some immunity but people may still carry and transmit virus
Past COVID-19 infection provides some immunity but people may still carry and transmit virus – Public Health England See also: Covid-19: Past infection provides 83% protection for five months but may not stop transmission, study finds – The BMJ AND COVID reinfections are unusual — but could still help the virus to spread – Nature AND […]
The post [Preprint] Past COVID-19 infection provides some immunity but people may still carry and transmit virus appeared first on Links Medicus.
[Preprint] Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact
Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact – medRxiv Related: Explanations for ‘long Covid’ remain elusive. For now, believing patients and treating symptoms is the best doctors can do – STAT AND Long COVID: who is at risk? – The Conversation Commentary on Twitter How long is #LongCovid?The […]
The post [Preprint] Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact appeared first on Links Medicus.
Long Covid: 6-month consequences of COVID-19 in patients discharged from hospital
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study – The Lancet Commentaries: Most patients hospitalized for Covid-19 still have symptoms six months later, China study finds AND Long-term follow-up of recovered patients with COVID-19 – The Lancet Commentary on Twitter Largest #LongCovid cohort @TheLancet just published:6 months post-hospital, —76% still […]
The post Long Covid: 6-month consequences of COVID-19 in patients discharged from hospital appeared first on Links Medicus.
[Press release – results not published yet] International trials of blood thinners in critically ill COVID-19 patients pause due to futility
International trials of blood thinners in critically ill COVID-19 patients pause due to futility – NIH News Releases Commentary on Twitter The 3 largest RCTs of therapeutic #anticoagulation for #COVID19 pts in the ICU have ALL been stopped early for futility. (@remap_cap @ATTACC_COVID & #ACTIV4) Nothing published yet, but given the large n of […]
The post [Press release – results not published yet] International trials of blood thinners in critically ill COVID-19 patients pause due to futility appeared first on Links Medicus.
Sinovac vaccine 78% effective in Brazil trial, experts call for more details
Sinovac vaccine 78% effective in Brazil trial, experts call for more details – Reuters See also: Brazil announces ‘fantastic’ results for Chinese-made COVID-19 vaccine, but details remain sketchy – Science
The post Sinovac vaccine 78% effective in Brazil trial, experts call for more details appeared first on Links Medicus.
Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data
Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data – The BMJ Opinion
The post Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data appeared first on Links Medicus.